This poses the question of whether individuals with breast cancer and synchronous chronic inflammation who have elevated sE-selectin and CD44+ circulating tumor cells (CTCs) are predisposed to increased risk of organ metastasis. The gene discussed is CD44; the disease is breast cancer.